Alzheimer's disease (AD) is the most common type of dementia, making up approximately 70% of all cases. Those over the age of 65 are at a higher risk to develop AD. It diminishes cognitive, verbal and physical abilities by destroying brain cells. This in turn affects our ability to think, to learn new things, and to remember. Many scientific experts are working to ameliorate our understanding of this devastating disease, thus searching to find more effective treatments. Our clinics partner with pharmaceutical companies to conduct Phase II and III clinical trials for Alzheimer's Disease. Our unique contribution will revolutionize the fight against the disease. We provide care to patients, generate knowledge for the scientific community, continue to improve support, and access to clinical research.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Associate degree